Clene Inc Stock Alpha and Beta Analysis
| CLNN Stock | USD 5.07 0.24 4.52% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Clene Inc. It also helps investors analyze the systematic and unsystematic risks associated with investing in Clene over a specified time horizon. Remember, high Clene's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Clene's market risk premium analysis include:
Beta 2.76 | Alpha (0.69) | Risk 7.99 | Sharpe Ratio (0.08) | Expected Return (0.64) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Clene Backtesting, Clene Valuation, Clene Correlation, Clene Hype Analysis, Clene Volatility, Clene History and analyze Clene Performance. Clene Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Clene market risk premium is the additional return an investor will receive from holding Clene long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Clene. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Clene's performance over market.| α | -0.69 | β | 2.76 |
Clene expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Clene's Buy-and-hold return. Our buy-and-hold chart shows how Clene performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Clene Market Price Analysis
Market price analysis indicators help investors to evaluate how Clene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Clene shares will generate the highest return on investment. By understating and applying Clene stock market price indicators, traders can identify Clene position entry and exit signals to maximize returns.
Clene Return and Market Media
The median price of Clene for the period between Wed, Oct 29, 2025 and Tue, Jan 27, 2026 is 6.77 with a coefficient of variation of 25.79. The daily time series for the period is distributed with a sample standard deviation of 1.94, arithmetic mean of 7.52, and mean deviation of 1.72. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Oculis Holding AG Reports Q3 Loss, Beats Revenue Estimates | 11/10/2025 |
2 | Clene Announces Statistically Significant ALS Biomarker Results Supporting Accelerated Approval Pathway for CNM-Au8 | 12/03/2025 |
3 | Disposition of 37235 shares by Ugwumba Chidozie of Clene at 5.94 subject to Rule 16b-3 | 12/05/2025 |
4 | Disposition of 21463 shares by Ugwumba Chidozie of Clene at 5.7 subject to Rule 16b-3 | 12/08/2025 |
5 | Disposition of 15031 shares by Ugwumba Chidozie of Clene at 5.95 subject to Rule 16b-3 | 12/09/2025 |
6 | Disposition of 7603 shares by Ugwumba Chidozie of Clene at 6.79 subject to Rule 16b-3 | 12/12/2025 |
7 | Disposition of 10580 shares by Ugwumba Chidozie of Clene at 6.49 subject to Rule 16b-3 | 12/15/2025 |
8 | Disposition of 2884 shares by Ugwumba Chidozie of Clene at 6.61 subject to Rule 16b-3 | 12/17/2025 |
9 | Disposition of 4367 shares by Ugwumba Chidozie of Clene at 6.54 subject to Rule 16b-3 | 12/22/2025 |
10 | Disposition of 424358 shares by Ugwumba Chidozie of Clene at 0.001 subject to Rule 16b-3 | 12/23/2025 |
11 | Disposition of 3350 shares by Ugwumba Chidozie of Clene at 6.32 subject to Rule 16b-3 | 12/26/2025 |
12 | Disposition of 13095 shares by Ugwumba Chidozie of Clene at 5.81 subject to Rule 16b-3 | 12/31/2025 |
13 | Disposition of 4015 shares by Ugwumba Chidozie of Clene at 5.73 subject to Rule 16b-3 | 01/02/2026 |
14 | Disposition of 5869 shares by Ugwumba Chidozie of Clene at 5.87 subject to Rule 16b-3 | 01/05/2026 |
15 | Disposition of 3111 shares by Ugwumba Chidozie of Clene at 6.04 subject to Rule 16b-3 | 01/06/2026 |
16 | Disposition of 38 shares by Ugwumba Chidozie of Clene at 6.29 subject to Rule 16b-3 | 01/07/2026 |
17 | Disposition of 3195 shares by Ugwumba Chidozie of Clene at 6.09 subject to Rule 16b-3 | 01/08/2026 |
18 | Clene Announces Registered Direct Offering of Over 28 Million | 01/09/2026 |
19 | Clene Announces Additional CNM-Au8 Biomarker Data Supporting Potential NDA Filing for Upcoming In-Person FDA Meeting | 01/12/2026 |
20 | Disposition of 19621 shares by Ugwumba Chidozie of Clene at 5.12 subject to Rule 16b-3 | 01/14/2026 |
21 | Disposition of 7923 shares by Ugwumba Chidozie of Clene at 5.13 subject to Rule 16b-3 | 01/16/2026 |
22 | Disposition of 12119 shares by Ugwumba Chidozie of Clene at 5.05 subject to Rule 16b-3 | 01/21/2026 |
23 | Acquisition by Etherington Robert Dee of 75000 shares of Clene at 5.42 subject to Rule 16b-3 | 01/22/2026 |
About Clene Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Clene or other stocks. Alpha measures the amount that position in Clene Inc has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Payables Turnover | 0.0805 | 0.0565 | 0.0649 | 0.0617 | Days Of Inventory On Hand | 111.61 | 354.57 | 407.76 | 404.35 |
Clene Upcoming Company Events
As portrayed in its financial statements, the presentation of Clene's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Clene's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Clene's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Clene. Please utilize our Beneish M Score to check the likelihood of Clene's management manipulating its earnings.
| 11th of March 2024 Upcoming Quarterly Report | View | |
| 10th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 11th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Clene
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Clene Backtesting, Clene Valuation, Clene Correlation, Clene Hype Analysis, Clene Volatility, Clene History and analyze Clene Performance. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Clene technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.